Literature DB >> 8265096

Amplification of the c-myc proto-oncogene in soft tissue sarcomas.

C Barrios1, J S Castresana, J Ruiz, A Kreicbergs.   

Abstract

Soft tissue sarcoma fresh specimens from 23 patients were screened for genetic abnormalities of 3 cellular oncogenes, i.e., c-myc and c-myb and c-Ha-ras. Southern blot hybridization analysis demonstrated amplification of the c-myc gene (4- to 8-fold) in 7 cases, i.e., 3 malignant fibrous histiocytomas, 1 liposarcoma, 1 fibrosarcoma, 1 lymphoma of the soft tissues and 1 synovial sarcoma. Amplification of the c-myc gene was not associated to other genetic alterations such as gene rearrangement. Hybridizations with c-myb and c-Ha-ras probes showed no gene abnormalities in this series. Our results indicate that c-myc oncogene amplification may play an important role in the development of certain soft tissue sarcomas as it has been found for other human malignancies. The clinical significance of these features remains to be established.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8265096     DOI: 10.1159/000227302

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  13 in total

Review 1.  New advances in the molecular biology of musculoskeletal neoplasms.

Authors:  J A Morcuende; J A Buckwalter
Journal:  Iowa Orthop J       Date:  1997

2.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.

Authors:  Hye-Ra Lee; Sultan Doğanay; Brian Chung; Zsolt Toth; Kevin Brulois; Stacy Lee; Zhansaya Kanketayeva; Pinghui Feng; Taekjip Ha; Jae U Jung
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability.

Authors:  Petra Baresova; Paula M Pitha; Barbora Lubyova
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 4.  New therapeutic targets in soft tissue sarcoma.

Authors:  Elizabeth G Demicco; Robert G Maki; Dina C Lev; Alexander J Lazar
Journal:  Adv Anat Pathol       Date:  2012-05       Impact factor: 3.875

5.  Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma.

Authors:  Devyani Samantarrai; Mousumi Sahu; Jyoti Roy; Bedanta Ballav Mohanty; Garima Singh; Chandra Bhushan; Bibekanand Mallick
Journal:  Sci Rep       Date:  2015-05-18       Impact factor: 4.379

6.  Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.

Authors:  H Watanabe; K Shimokado; T Asahara; K Dohi; O Niwa
Journal:  Jpn J Cancer Res       Date:  1999-01

7.  Frequent beta-catenin abnormalities in bone and soft-tissue tumors.

Authors:  K Iwao; Y Miyoshi; G Nawa; H Yoshikawa; T Ochi; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  1999-02

8.  Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.

Authors:  Tetsuya Sekita; Tesshi Yamada; Eisuke Kobayashi; Akihiko Yoshida; Toru Hirozane; Akira Kawai; Yuko Uno; Hideki Moriyama; Masaaki Sawa; Yuichi Nagakawa; Akihiko Tsuchida; Morio Matsumoto; Masaya Nakamura; Robert Nakayama; Mari Masuda
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

9.  Molecular approaches to sarcoma therapy.

Authors:  R J Olsen; S R Tarantolo; S H Hinrichs
Journal:  Sarcoma       Date:  2002

Review 10.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.